A review of Lewy body disease, an emerging concept of cortical dementia

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 10, Issue 3, 1998, Pages 267-279

  Papka, Michelle ^a   Rubio, Ana ^a   Schiffer, Randolph B ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR STIMULATING AGENT; LEVODOPA; NEUROLEPTIC AGENT;

ALZHEIMER DISEASE; BRAIN CORTEX; CLINICAL FEATURE; COGNITIVE DEFECT; CONFUSION; DEMENTIA; DIAGNOSTIC APPROACH ROUTE; HALLUCINATION; HUMAN; LEWY BODY; NEUROLOGIC EXAMINATION; NOMENCLATURE; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY;

EID: 0031822077     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.10.3.267     Document Type: Review

References (73)

1. Perry R, Irving D, Blessed G, et al: Clinically and pathologically distinct form of dementia in the elderly. Lancet 1989; 1:166
2. Hansen L, Salmon D, Galasko D, et al: The Lewy body variant of Alzheimer's disease: a clinical and pathological entity. Neurology 1990; 40:1-8
3. McKeith I, Perry R, Fairbairn A, et al: Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 1992; 22:911-922
4. Perry R, Irving D, Blessed G, et al: Senile dementia of Lewy body type: a clinical and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 1990; 95:119-139
5. Kondo N: [A study on the difference between clinical and neuropathologic diagnoses of age-related dementing illnesses: correlations with Hachinski's ischemic score (Japanese).] Seishin Shinkeigaku Zasshi 1995; 97:825-846
6. McKeith I, Fairbairn A, Perry R, et al: The clinical diagnosis and misdiagnosis of senile dementia of Lewy body type (SDLT). Br J Psychiatry 1994; 165:324-332
7. Derouesne C: [Dementia: diagnostic problems (French).] Therapie 1993; 48:189-193
8. Dickson D, Ruan D, Crystal H, et al: Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neuntes specific to DLBD. Neurology 1991; 41:1402-1409
9. Hansen L, Galasko D: Lewy body disease. Curr Opin Neurol 1992; 5:889-894
10. Dickson D, Davies P, Mayeux R, et al: Diffuse Lewy body disease: neuropathologic and biochemical studies of six patients. Acta Neuropathol 1987; 75:8-15
11. Yoshimura M: Cortical changes in the parkinsonian brain: a contribution to the delineation of "diffuse Lewy body disease." J Neurol 1983; 229:17-32
12. Differ S, Mirra S: Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients. Neurology 1987; 37:754-760
13. Tretiakoff C: Contribution a létude de l'anatomie pathologique du locus niger de Soemmering avec quelques deductions relatives à la pathogenie des troubles du tonus musculaires et de la maladie de Parkinson [Contributions to the study of the substantia nigra of Sömmering with relation to the pathogenesis of the muscular tone problems in Parkinson's disease]. Thesis, University of Paris, 1919
14. Lewy FH: Paralysis agitans, I: pathologische anatomie, in Handbuch der Neurologie, edited by Lewandowsky M. Berlin, Springer, 1912, pp 920-933
15. Okazaki H, Lipkin LE, Aronson SM: Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion. J Neuropathol Exp Neurol 1961; 20:237-244
16. Woodard JS: Concentric hyalin inclusion body formation in mental disease: analysis of 27 cases. J Neuropathol Exp Neurol 1962; 21:442-449
17. Kosaka K, Matsushita M, Oyanagi S, et al: A clinicopathological study of the "Lewy body disease." Psychiatria et Neurologia Japonica 1980; 82:292-311
18. Forno LS: Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 1996; 55:259-272
19. Jellinger K: Morphology of Alzheimer's disease and related disorders, in Alzheimer's disease: epidemiology, neuropathology, neurochemistry and clinics, edited by Maurer K, Riederer P, Beckman H. New York, Springer-Verlag, 1990, pp 61-70
20. Dickson DW, Schmidt ML, Lee VMY, et al: Immunoreactivity profile of hippocampal Ca2/3 neuntes in diffuse Lewy body disease. Acta Neuropathol (Berl) 1994; 87:269-276
21. Kim H, Gearing M, Mirra SS: Ubiquitin positive Ca2/3 neurites in hippocampus coexist with cortical Lewy bodies. Neurology 1995; 45:1768-1770
22. Hughes AJ, Daniel SE, Kilford L, et al: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55:181-184
23. Hansen LA, Masliah E, Galasko D, et al: Plaque-only Alzheimer disease is usually the Lewy body variant, and vice versa. J Neuropathol Exp Neurol 1993; 52:648-654
24. Forstl H, Burns A, Luthert P, et al: The Lewy body variant of Alzheimer's disease: clinical and pathological findings. Br J Psychiatry 1993; 162:385-392
25. Lippa CF, Smith TW, Swearer JM: Alzheimer's disease and Lewy body disease: a comparative clinicopathological study. Ann Neurol 1994; 35:81-88
26. McKeith IG, Galasko D, Kosaka K, et al: Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy Bodies (DLB). Neurology 1996; 47:1113-1124
27. Gibb W, Luthert P, Janota I, et al: Cortical Lewy body dementia: clinical features and classification. J Neurol Neurosurg Psychiatry 1989; 52:185-192
28. McKeith I, Fairbairn A, Perry R, et al: Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ 1992; 305:673-678
29. Perry E, Kerwin J, Perry R, et al: Cerebral cholinergic activity is related to the incidence of visual hallucinations in senile dementia of Lewy body type. Dementia 1990; 1:2-4
30. Perry E, Marshall E, Kerwin J, et al: Evidence of a monoaminergic-cholinergic imbalance related to visual hallucinations in Lewy body dementia. J Neurochem 1990; 55:1454-1456
31. Burkhardt C, Filley C, Kleinschmidt-DeMasters B, et al: Diffuse Lewy body disease and progressive dementia. Neurology 1988; 38:1520-1528
32. Crystal HA, Dickson DW, Lizardi JE, et al: Antemortem diagnosis of diffuse Lewy body disease. Neurology 1990; 40:1523-1528
33. Kuzuhara S, Yoshimura M: Clinical and neuropathologic aspects of diffuse Lewy body disease in the elderly. Adv Neurol 1993; 60:464-469
34. Kosaka K: Diffuse Lewy body disease in Japan. J Neurol 1990; 237:197-204
35. Kosaka K: Dementia and neuropathology in Lewy body disease. Adv Neurol 1993; 60:456-463
36. McKeith I, Fairbairn A, Bothwell R, et al: An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology 1994; 44:872-877
37. Klatka L, Louis E, Schiffer RB: Psychiatric features in diffuse Lewy body disease: a clinicopathologic study using Alzheimer's disease and Parkinson's disease comparison groups. Neurology 1996; 47:1148-1152
38. Byrne E, Lennox G, Lowe J, et al: Diffuse Lewy body disease: clinical features in 15 cases. J Neurol Neurosurg Psychiatry 1989; 52:709-717
39. Dalla Barba G, Boller F: Non-Alzheimer degenerative dementias. Curr Opin Neurol 1994; 7:305-309
40. Katzman R, Galasko D, Saitoh T, et al: Genetic evidence that the Lewy body variant is indeed a phenotypic variant of Alzheimer's disease. Brain Cogn 1995; 28:259-265
41. Lippa C, Smith T, Saunders A, et al: Apolipoprotein E genotype and Lewy body disease. Neurology 1995; 45:97-103
42. Galasko D, Saitoh T, Xia Y, et al: The apolipoprotein E allele epsilon 4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease. Neurology 1994; 44:1950-1951
43. De Vos R, Jansen E, Stam F, et al: Lewy body disease clinicopathological correlations in 18 consecutive cases of Parkinson's disease with and without dementia. Clin Neurol Neurosurg 1995; 97:13-22
44. Huber S, Cummings J (eds): Parkinson's Disease: Neurobehavioral Aspects. New York, Oxford University Press, 1992
45. Brown R, Marsden C: How common is dementia in Parkinson's disease? Lancet 1984; 1:1262-1265
46. Blessed G, Roth M, Tomlinson B: The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968; 114:797-811
47. Samuel W, Galasko D, Masliah E, et al: Neocortical Lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease. J Neuropathol Exp Neurol 1996; 55:44-52
48. Holstein M, Folstein S, McHugh P: "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
49. Mattis S: Mental status examination for organic mental syndrome in the elderly patient, in Geriatric Psychiatry, edited by Bellak L, Karasu TB. New York, Grune and Stratton, 1976
50. Galloway P, Sahgal A, McKeith I, et al: Visual pattern recognition memory and learning deficits in senile dementia of Alzheimer and Lewy body types. Dementia 1992; 3:101-107
51. Sahgal A, Galloway P, McKeith I, et al: Matching-to-sample deficits in patients with senile dementias of the Alzheimer and Lewy body types. Arch Neurol 1992; 49:1043-1046
52. Zola-Morgan S, Squire L: Memory impairment in monkeys following lesions of the hippocampus. Behav Neurosci 1986; 100:155-160
53. Lennox G, Lowe J, Godwin-Austen R, et al: Diffuse Lewy body disease: an important differential diagnosis in dementia with extrapyramidal features. Prog Clin Biol Res 1989; 317:121-130
54. Hakim A, Mathieson G: Dementia in Parkinson's disease: a neuropathologic study. Neurology 1979; 29:1209-1214
55. Perry E, Curtis M, Dick D, et al: Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease. J Neurol Neurosurg Psychiatry 1985; 48:413-421
56. Rogers J, Brogan D, Mirra S: The nucleus basalis of Meynert in neurological disease: a quantitative morphological study. Ann Neurol 1985; 17:163-170
57. Byrne E, Lennox G, Lowe J, et al: Diffuse Lewy body disease: the clinical features. Adv Neurol 1990; 53:283-286
58. Gibb W, Esiri M, Lees A: Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain 1987; 110:1131-1153
59. Louis E, Klatka L, Liu X et al: Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's disease. Neurology 1997; 48:376-380
60. Louis E, Fahn S: Pathologically diagnosed diffuse Lewy body disease and Parkinson's disease: do the parkinsonian features differ? Adv Neurol 1996; 69:311-314
61. Rajput A, Pahwa R, Pahwa P, et al: Prognostic significance of the onset mode in parkinsonism. Neurology 1993; 43:829-840
62. Clark R, Lord S, Webster I: Clinical parameters associated with falls in an elderly population. Gerontology 1993; 39:117-123
63. Van Dijk P, Meulenberg O, van de Sande H, et al: Falls in dementia patients. Gerontologist 1993; 33:200-204
64. Louis E, Goldman J, Powers J, et al: Parkinsonism features of eight pathologically diagnosed cases of diffuse Lewy body disease. Mov Disord 1995; 10:188-194
65. Filley C: Neuropsychiatric features of Lewy body disease. Brain Cogn 1995; 28:229-239
66. Klatka L, Schiffer RB, Powers J, et al: Incorrect diagnosis of Alzheimer's disease. Arch Neurol 1996; 53:35-42
67. Mark M, Dickson D, Sage J, et al: The clinicopathologic spectrum of Lewy body disease. Adv Neurol 1996; 69:315-318
68. Sima A, Clark A, Sternberger N, et al: Lewy body dementia without Alzheimer changes. Can J Neurol Sci 1986; 13:490-497
69. Mann DMA, Snowden JS: The topographic distribution of brain atrophy in cortical Lewy body disease: comparison with Alzheimer's disease. Acta Neuropathol 1995; 89:178-183
70. Byrne E, Lennox G, Lowe J, et al: Dementia associated with cortical Lewy bodies: proposed clinical diagnostic criteria. Dementia 1991; 2:283-284
71. Wilcock G, Scott M: Tacrine for senile dementia of Alzheimer's or Lewy body type (letter). Lancet 1994; 344:544
72. Summers W, Majorski L, Marsh G, et al: Oral tetrahydroaminoacridine in long term treatment of senile dementia, Alzheimer type. N Engl J Med 1986; 315:1241-1245
73. Chacko R, Hurley R, Jankovic J: Clozapine use in diffuse Lewy body disease. J Neuropsychiatry Clin Neurosci 1993; 5:206-208